Review



dataviewer 2d/3d micro-ct slice visualization software  (Skyscan Corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Skyscan Corporation dataviewer 2d/3d micro-ct slice visualization software
    Dataviewer 2d/3d Micro Ct Slice Visualization Software, supplied by Skyscan Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/dataviewer+2d+3d+micro+ct+slice+visualization+software/10__1016_slash_j__carbon__2021__05__003-138-12-22
    Average 90 stars, based on 1 article reviews
    dataviewer 2d/3d micro-ct slice visualization software - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Software:

    Article Title: Dual aldehyde cross-linked hyaluronic acid hydrogels loaded with PRP and NGF biofunctionalized PEEK interfaces to enhance osteogenesis and vascularization
    Article Snippet: .. Images were viewed by 3D visualization software (Skyscan 1076 Scanner, Bruker Micro-CT, NV, Kontich, Belgium), and BV/TV was statistically analyzed by CTAn software (SkyScan, Belgium). ..

    Article Title: Biomimetic gradient microporous scaffold with a triply periodic minimal surface enhances osseointegration by modulating macrophage polarization
    Article Snippet: .. 3D reconstructions of the acquired images were generated using multimodal 3D visualization software (Skyscan 1076 Scanner, Bruker Micro-CT, NV, Kontich, Belgium). ..

    Article Title: Enhanced Osseointegration of Ti6Al4V Implants via Sub-300 μm Microporous Structures Fabricated by Direct Ink Writing
    Article Snippet: .. The scanned specimens were reconstructed using multimodality 3D visualization software (Skyscan 1076 scanner, Bruker Micro-CT, Kontich, Belgium), and bone morphometric parameters, including bone volume fraction (BV/TV) and trabecular thickness (Tb. ..

    Micro-CT:

    Article Title: Dual aldehyde cross-linked hyaluronic acid hydrogels loaded with PRP and NGF biofunctionalized PEEK interfaces to enhance osteogenesis and vascularization
    Article Snippet: .. Images were viewed by 3D visualization software (Skyscan 1076 Scanner, Bruker Micro-CT, NV, Kontich, Belgium), and BV/TV was statistically analyzed by CTAn software (SkyScan, Belgium). ..

    Article Title: Biomimetic gradient microporous scaffold with a triply periodic minimal surface enhances osseointegration by modulating macrophage polarization
    Article Snippet: .. 3D reconstructions of the acquired images were generated using multimodal 3D visualization software (Skyscan 1076 Scanner, Bruker Micro-CT, NV, Kontich, Belgium). ..

    Article Title: Enhanced Osseointegration of Ti6Al4V Implants via Sub-300 μm Microporous Structures Fabricated by Direct Ink Writing
    Article Snippet: .. The scanned specimens were reconstructed using multimodality 3D visualization software (Skyscan 1076 scanner, Bruker Micro-CT, Kontich, Belgium), and bone morphometric parameters, including bone volume fraction (BV/TV) and trabecular thickness (Tb. ..

    Generated:

    Article Title: Biomimetic gradient microporous scaffold with a triply periodic minimal surface enhances osseointegration by modulating macrophage polarization
    Article Snippet: .. 3D reconstructions of the acquired images were generated using multimodal 3D visualization software (Skyscan 1076 Scanner, Bruker Micro-CT, NV, Kontich, Belgium). ..

    other:

    Article Title: Three-dimensional printing of complex graphite structures
    Article Snippet: 3D image registration and reorientation were carried out using Jo ur al Pr e-p roo f DataViewer 2D/3D Micro-CT Slice Visualization software (Skyscan, Bruker, Belgium).

    Article Title: Advanced biomimetic design strategies for porous structures promoting bone integration with additive-manufactured Ti6Al4V scaffolds
    Article Snippet: A multimodal 3D visualization software (Skyscan 1076 Scanner, Bruker Micro-CT, NV, Kontich, Belgium) was used to perform 3D reconstruction of the acquired images, and image analysis was performed using a bone analyzer (CT analyzer 1.17.7.2 software, Kontich, Belgium).

    Article Title: Evaluation of mesial root canal configuration of mandibular first molars using micro-computed tomography
    Article Snippet: The cross-sectional images were transferred to a 3D visualization software package (CTan for 2D visualization and 2D/3D analysis, CTvol for realistic 3D visualization, and DataViewer v.1172 SkyScan micro-CT software for 3D analysis on sagittal, coronal, and axial slices).

    Article Title: Damage-tolerant 3D-printed ceramics via conformal coating.
    Article Snippet: The different datasets were reoriented and registered with each other by DataViewer 2D/3D Micro-CT Slice Visualization software (Skyscan, Bruker, Belgium), and the 3D models of the samples were created using CTVox 3D Micro-CT Volume Rendering software (Skyscan, Bruker, Belgium).

    Article Title: Bifunctionalized hydrogels promote angiogenesis and osseointegration at the interface of three-dimensionally printed porous titanium scaffolds
    Article Snippet: A multimodal 3D visualization software (Skyscan 1,076 Scanner, Bruker Micro-CT, NV, Kontich, Belgium) was used to perform 3D reconstruction of the acquired images, and image analysis was performed using a bone analyzer (CT analyzer 1.17.7.2 software, Kontich, Belgium).



    Similar Products

    99
    Bruker Corporation 3d model visualization software ctvol v2 3 2 0
    3d Model Visualization Software Ctvol V2 3 2 0, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/Micro-CT/pm42162236-48-16-22
    Average 99 stars, based on 1 article reviews
    3d model visualization software ctvol v2 3 2 0 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    90
    Bruker Corporation 3d visualization software ctvol micro-ct
    3d Visualization Software Ctvol Micro Ct, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/3d+model+visualisation+software+bruker+micro+ct/pm40543083-188-1-5
    Average 90 stars, based on 1 article reviews
    3d visualization software ctvol micro-ct - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Micro Photonics Inc micro-ct 3d visualization software
    Micro Ct 3d Visualization Software, supplied by Micro Photonics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/micro+ct+3d+visualization+software/10__1016_slash_j__mtbio__2024__101353-359-0-4
    Average 90 stars, based on 1 article reviews
    micro-ct 3d visualization software - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    99
    Bruker Corporation realistic 3d visualization software
    Realistic 3d Visualization Software, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/Micro-CT/10__1007_slash_s12274___024___6656___8-130-9-12
    Average 99 stars, based on 1 article reviews
    realistic 3d visualization software - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Bruker Corporation 3d model visualization software
    Fig. 2 GNPs treatment alleviated ACLT-induced OA. (A) To evaluate the mitigation of GNPs on OA, C57BL/6J mice (6–8 weeks, male, 20–25 g) were selected to undergo anterior cruciate ligament transection surgery to induce the OA models, and randomly assigned to ACLTVehicle or ACLTGNPs group. The ACLTVehicle and ACLTGNPs groups were given continuous gavage with the equivalent amount of saline and GNPs for 8 weeks, respectively. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle and ACLTGNPs groups. (C) Immunohistochemical staining of the expres sion of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of Osteoarthritis Research Society International (OARSI) histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantita tive analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and <t>3D</t> images of distal femur. The coloring parts represent the regions of interest (ROI) for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images <t>of</t> <t>proximal</t> tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (K) Representative images of IF staining of TRAP in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (L) Representative images of IF staining of Netrin-1 in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (M) Representative images of IF staining of CGRP+ fibers in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (N) Quantitative analysis of TRAP staining. (O) Quantitative analysis of Netrin-1staining. (P) Quantitative analysis of CGRP+ fibers staining. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)
    3d Model Visualization Software, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/Micro-CT/pm38589904-105-20-25
    Average 99 stars, based on 1 article reviews
    3d model visualization software - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    90
    Skyscan Corporation dataviewer 2d/3d micro-ct slice visualization software
    Fig. 2 GNPs treatment alleviated ACLT-induced OA. (A) To evaluate the mitigation of GNPs on OA, C57BL/6J mice (6–8 weeks, male, 20–25 g) were selected to undergo anterior cruciate ligament transection surgery to induce the OA models, and randomly assigned to ACLTVehicle or ACLTGNPs group. The ACLTVehicle and ACLTGNPs groups were given continuous gavage with the equivalent amount of saline and GNPs for 8 weeks, respectively. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle and ACLTGNPs groups. (C) Immunohistochemical staining of the expres sion of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of Osteoarthritis Research Society International (OARSI) histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantita tive analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and <t>3D</t> images of distal femur. The coloring parts represent the regions of interest (ROI) for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images <t>of</t> <t>proximal</t> tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (K) Representative images of IF staining of TRAP in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (L) Representative images of IF staining of Netrin-1 in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (M) Representative images of IF staining of CGRP+ fibers in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (N) Quantitative analysis of TRAP staining. (O) Quantitative analysis of Netrin-1staining. (P) Quantitative analysis of CGRP+ fibers staining. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)
    Dataviewer 2d/3d Micro Ct Slice Visualization Software, supplied by Skyscan Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/dataviewer+2d+3d+micro+ct+slice+visualization+software/10__1016_slash_j__carbon__2021__05__003-138-12-22
    Average 90 stars, based on 1 article reviews
    dataviewer 2d/3d micro-ct slice visualization software - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    86
    Skyscan Corporation dataviewer 2d 3d micro ct slice visualization software
    Fig. 2 GNPs treatment alleviated ACLT-induced OA. (A) To evaluate the mitigation of GNPs on OA, C57BL/6J mice (6–8 weeks, male, 20–25 g) were selected to undergo anterior cruciate ligament transection surgery to induce the OA models, and randomly assigned to ACLTVehicle or ACLTGNPs group. The ACLTVehicle and ACLTGNPs groups were given continuous gavage with the equivalent amount of saline and GNPs for 8 weeks, respectively. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle and ACLTGNPs groups. (C) Immunohistochemical staining of the expres sion of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of Osteoarthritis Research Society International (OARSI) histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantita tive analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and <t>3D</t> images of distal femur. The coloring parts represent the regions of interest (ROI) for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images <t>of</t> <t>proximal</t> tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (K) Representative images of IF staining of TRAP in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (L) Representative images of IF staining of Netrin-1 in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (M) Representative images of IF staining of CGRP+ fibers in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (N) Quantitative analysis of TRAP staining. (O) Quantitative analysis of Netrin-1staining. (P) Quantitative analysis of CGRP+ fibers staining. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)
    Dataviewer 2d 3d Micro Ct Slice Visualization Software, supplied by Skyscan Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/2d+3d+ct+dataviewer+micro+slice+software+visualization/pmc08262818-152-11-17
    Average 86 stars, based on 1 article reviews
    dataviewer 2d 3d micro ct slice visualization software - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 2 GNPs treatment alleviated ACLT-induced OA. (A) To evaluate the mitigation of GNPs on OA, C57BL/6J mice (6–8 weeks, male, 20–25 g) were selected to undergo anterior cruciate ligament transection surgery to induce the OA models, and randomly assigned to ACLTVehicle or ACLTGNPs group. The ACLTVehicle and ACLTGNPs groups were given continuous gavage with the equivalent amount of saline and GNPs for 8 weeks, respectively. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle and ACLTGNPs groups. (C) Immunohistochemical staining of the expres sion of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of Osteoarthritis Research Society International (OARSI) histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantita tive analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and 3D images of distal femur. The coloring parts represent the regions of interest (ROI) for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images of proximal tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (K) Representative images of IF staining of TRAP in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (L) Representative images of IF staining of Netrin-1 in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (M) Representative images of IF staining of CGRP+ fibers in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (N) Quantitative analysis of TRAP staining. (O) Quantitative analysis of Netrin-1staining. (P) Quantitative analysis of CGRP+ fibers staining. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)

    Journal: Journal of nanobiotechnology

    Article Title: Gold nanoparticles exhibit anti-osteoarthritic effects via modulating interaction of the "microbiota-gut-joint" axis.

    doi: 10.1186/s12951-024-02447-y

    Figure Lengend Snippet: Fig. 2 GNPs treatment alleviated ACLT-induced OA. (A) To evaluate the mitigation of GNPs on OA, C57BL/6J mice (6–8 weeks, male, 20–25 g) were selected to undergo anterior cruciate ligament transection surgery to induce the OA models, and randomly assigned to ACLTVehicle or ACLTGNPs group. The ACLTVehicle and ACLTGNPs groups were given continuous gavage with the equivalent amount of saline and GNPs for 8 weeks, respectively. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle and ACLTGNPs groups. (C) Immunohistochemical staining of the expres sion of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of Osteoarthritis Research Society International (OARSI) histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantita tive analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and 3D images of distal femur. The coloring parts represent the regions of interest (ROI) for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images of proximal tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (K) Representative images of IF staining of TRAP in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (L) Representative images of IF staining of Netrin-1 in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (M) Representative images of IF staining of CGRP+ fibers in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (N) Quantitative analysis of TRAP staining. (O) Quantitative analysis of Netrin-1staining. (P) Quantitative analysis of CGRP+ fibers staining. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)

    Article Snippet: The subchondral bone regions of the distal femur and proximal tibia were selected as the region of interest (ROI), and 3D model visualization software (CTvox, Bruker micro-CT, ver.3.3.1.0) was used for 3-dimensional histomorphometric analysis.

    Techniques: Saline, Staining, Immunohistochemical staining, Expressing

    Fig. 3 The protective effect of GNPs against ACLT-induced OA disappeared after gut microbiota consumption. (A) The schematic diagram of gut micro biota consumption experiments. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle+ABX and ACLTGNPs+ABX groups. (C) Immunohistochemical staining of the expression of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Ag grecan in articular cartilage of sections. (E) Quantitative analysis of OARSI histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantitative analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and 3D images of distal femurs. The col oring parts represent the ROI for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 10. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images of proximal tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 10. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)

    Journal: Journal of nanobiotechnology

    Article Title: Gold nanoparticles exhibit anti-osteoarthritic effects via modulating interaction of the "microbiota-gut-joint" axis.

    doi: 10.1186/s12951-024-02447-y

    Figure Lengend Snippet: Fig. 3 The protective effect of GNPs against ACLT-induced OA disappeared after gut microbiota consumption. (A) The schematic diagram of gut micro biota consumption experiments. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle+ABX and ACLTGNPs+ABX groups. (C) Immunohistochemical staining of the expression of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Ag grecan in articular cartilage of sections. (E) Quantitative analysis of OARSI histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantitative analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and 3D images of distal femurs. The col oring parts represent the ROI for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 10. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images of proximal tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 10. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)

    Article Snippet: The subchondral bone regions of the distal femur and proximal tibia were selected as the region of interest (ROI), and 3D model visualization software (CTvox, Bruker micro-CT, ver.3.3.1.0) was used for 3-dimensional histomorphometric analysis.

    Techniques: Staining, Immunohistochemical staining, Expressing

    Fig. 4 Fecal microbiota transplantation alleviated ACLT-induced OA. (A) The schematic diagram of the FMT experiments. (B) H&E, Safranine O and Tolu idine Blue staining of femur articular cartilage in ACLTVehicle+FMT and ACLTGNPs+FMT group. (C) Immunohistochemical staining of the expression of MMP- 13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of OARSI histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantitative analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and 3D images of distal femurs. The coloring parts represent the ROI for analysis. Quantifica tion of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 5. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images of proximal tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 5. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)

    Journal: Journal of nanobiotechnology

    Article Title: Gold nanoparticles exhibit anti-osteoarthritic effects via modulating interaction of the "microbiota-gut-joint" axis.

    doi: 10.1186/s12951-024-02447-y

    Figure Lengend Snippet: Fig. 4 Fecal microbiota transplantation alleviated ACLT-induced OA. (A) The schematic diagram of the FMT experiments. (B) H&E, Safranine O and Tolu idine Blue staining of femur articular cartilage in ACLTVehicle+FMT and ACLTGNPs+FMT group. (C) Immunohistochemical staining of the expression of MMP- 13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of OARSI histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantitative analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and 3D images of distal femurs. The coloring parts represent the ROI for analysis. Quantifica tion of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 5. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images of proximal tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 5. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)

    Article Snippet: The subchondral bone regions of the distal femur and proximal tibia were selected as the region of interest (ROI), and 3D model visualization software (CTvox, Bruker micro-CT, ver.3.3.1.0) was used for 3-dimensional histomorphometric analysis.

    Techniques: Transplantation Assay, Staining, Immunohistochemical staining, Expressing